Shakibai, Nasim
17  Ergebnisse:
Personensuche X
?
 
?
4

Impact of Clinical Factors and Treatments on SMARCB1 (INI‐1..:

Contrera, Kevin J. ; Shakibai, Nasim ; Su, Shirley Y....
Otolaryngology–Head and Neck Surgery.  169 (2023)  2 - p. 435-440 , 2023
 
?
6

Leukostasis retinopathy treated with Anti-VEGF therapy:

Shakibai, Nasim ; Chavala, Sai H.
American Journal of Ophthalmology Case Reports.  18 (2020)  - p. 100677 , 2020
 
?
7

Delayed capsular bag akreos IOL opacification after vitrect..:

Shakibai, Nasim ; Chavala, Sai H.
American Journal of Ophthalmology Case Reports.  18 (2020)  - p. 100676 , 2020
 
?
 
?
11

Leukostasis retinopathy treated with Anti-VEGF therapy:

Shakibai, Nasim ; Chavala, Sai H
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168348/.  , 2020
 
?
13

Analysis of sensorineural hearing loss in patients attendin..:

Nuhu D Ma'an ; Ishaku Turaki ; David Shwe...
https://journals.plos.org/globalpublichealth/article/file?id=10.1371/journal.pgph.0000685&type=printable.  , 2023
 
?
14

Analysis of sensorineural hearing loss in patients attendin..:

Nuhu D. Ma'an ; Ishaku Turaki ; David Shwe...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10128921/?tool=EBI.  , 2023
 
?
15

Delayed capsular bag akreos IOL opacification after vitrect..:

Nasim Shakibai ; Sai H. Chavala
http://www.sciencedirect.com/science/article/pii/S2451993619301756.  , 2020
 
1-15